Discover 4,047 paid clinical trials in Bronx, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 4,047
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
for
Anal Fistula
Location: New York NY
Sponsor: Weill Medical College of Cornell University
Sex: All
Age: 18+
Code: NCT04190862
Phase 1, Recruiting
A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004
for
Parkinson's Disease
Location: Commack NY, Vernon CT, Hershey PA, Boston MA,
Sponsor: Intec Pharma Ltd.
Sex: All
Age: 30 - 70+
Code: NCT02615873
Phase 3, Recruiting
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr
for
Prostate Cancer
Location: New York NY, Cleveland OH
Sponsor: Weill Medical College of Cornell University
Sex: Male
Age: 18+
Code: NCT05948657
Recruiting
Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC)
for
PSMA PET-Positive Castration-Resistant Prostate Cancer
Location: New York NY, Boston MA, Cleveland OH, Durham NC,
Sponsor: Convergent Therapeutics
Sex: Male
Age: 18+
Code: NCT06549465
Phase 2, Recruiting
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
for
Lung Cancer, Lung Cancer Metastatic, Brain Metastases,
Location: New York NY, Harrison NY, Rockville Centre NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT05419076
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Registry for People With Lung Cancer
for
Lung Cancer, Lung Cancer Stage I
Location: New York NY, Harrison NY, Uniondale NY, Montvale NJ,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT06424327
Recruiting
mHealth-CArdiac REhabilitation for INOCA
for
Ischemia
Location: New York NY
Sponsor: NYU Langone Health
Sex: All
Age: 18+
Code: NCT06829160
Recruiting
A Study to Prevent and Improve Sexual Health Concerns for People With Breast Cancer
for
Improve Sexual Health, Improve Vulvovaginal Health
Location: New York NY, Harrison NY, Uniondale NY, Montvale NJ,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: Female
Age: 18+
Code: NCT05910294
Recruiting
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
for
Advanced Solid Tumor Cancer
Location: New York NY, New Haven CT, Philadelphia PA,
Sponsor: Calico Life Sciences LLC
Sex: All
Age: 18+
Code: NCT04777994
Phase 1, Recruiting
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
for
Melanoma Stage IV, Solid Tumor
Location: New York NY, Boston MA, Richmond VA, Cincinnati OH,
Sponsor: Georgiamune Inc
Sex: All
Age: 18+
Code: NCT06425926
Phase 1, Phase 2, Recruiting
Diagnostic Study of Quantitative Imaging and Spectroscopy in Patients With Multiple Sclerosis
for
Multiple Sclerosis
Location: New York NY
Sponsor: National Center for Research Resources (NCRR)
Sponsor: Weill Medical College of Cornell University
Sex: All
Age: 1 - 21
Code: NCT03991169
Recruiting
Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab
for
Newly Diagnosed Glioblastoma
Location: New York NY, Durham NC, Houston TX
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06816927
Phase 2, Recruiting
APG-2575 in Combination With Novel Therapeutic Regimens in Subjects With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma, Amyloidosis
Location: New York NY, Cleveland OH, Jacksonville FL
Sponsor: Ascentage Pharma Group Inc.
Sex: All
Age: 18+
Code: NCT04942067
Phase 1, Phase 2, Recruiting
Considering Racial and Acculturation Stress in Addressing Trauma
for
Trauma-related PTSD
Location: New York NY
Sponsor: NYU Langone Health
Sex: All
Age: 5 - 17
Code: NCT05974176
Recruiting
Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer
for
Anatomic Stage III Breast Cancer AJCC v8,
Location: New York NY, Mineola NY, Boston MA, Columbus OH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05422794
Phase 1, Recruiting
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: New York NY, Baltimore MD, Richmond VA, Pittsburgh PA,